We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-2.77%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.85B
AUM Growth
+$375M
Cap. Flow
-$1.26B
Cap. Flow %
-25.93%
Top 10 Hldgs %
37.89%
Holding
140
New
14
Increased
21
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$50.2M
2
GILD icon
Gilead Sciences
GILD
+$48.7M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$32.8M
4
MRUS
Merus
MRUS
+$32.3M
5
GKOS icon
Glaukos
GKOS
+$31.8M

Top Sells

Rank Stock Value
1
KURA icon
Kura Oncology
KURA
+$25.7M
2
ORGO icon
Organogenesis Holdings
ORGO
+$24.7M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$22.2M
4
GDRX icon
GoodRx Holdings
GDRX
+$18.9M
5
NUVB icon
Nuvation Bio
NUVB
+$18.8M

Sector Composition

Rank Sector Weight
1 Healthcare 51.31%
2 Financials 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVL
76
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1.28M 0.03%
16,733
-6,118
-27% -$537K
RYTM icon
77
Rhythm Pharmaceuticals
RYTM
$7.25B
$1.21M 0.02%
291,005
– –
TOIIW
78
The Oncology Institute Warrant
TOIIW
$6.21M
$625K 0.01%
1,250,000
– –
ROIVW
79
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$600K 0.01%
1,000,000
– –
CABA icon
80
Cabaletta Bio
CABA
$458M
$492K 0.01%
464,252
– –
CMAXW
81
DELISTED
CareMax, Inc. Warrant
CMAXW
$484K 0.01%
672,000
– –
BFLY.WS
82
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$296K 0.01%
733,333
– –
QSIAW
83
DELISTED
Quantum-Si Inc Warrant
QSIAW
$188K ﹤0.01%
333,333
– –
SLGCW
84
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$91K ﹤0.01%
120,000
– –
PKBOW
85
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$76K ﹤0.01%
362,500
– –
REVHW
86
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$49K ﹤0.01%
200,000
– –
NUVB.WS
87
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$47K ﹤0.01%
166,666
– –
SNRHW
88
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$35K ﹤0.01%
500,000
– –
SRSAW
89
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$33K ﹤0.01%
333,333
– –
SRZNW icon
90
Surrozen Inc Warrant
SRZNW
$32K ﹤0.01%
166,666
– –
TLSIW icon
91
TriSalus Life Sciences Warrant
TLSIW
$27.8M
$28K ﹤0.01%
333,333
– –
EUCRW
92
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$22K ﹤0.01%
333,333
– –
TMPMW
93
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$19K ﹤0.01%
250,000
– –
OHPAW
94
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$11K ﹤0.01%
125,000
– –
WINT
95
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
AMWL icon
96
American Well
AMWL
$215M
– –
-19,556
Closed -$1.65M
BCAB icon
97
BioAtla
BCAB
$6.65M
– –
-5,780
Closed -$1.45M
BCRX icon
98
BioCryst Pharmaceuticals
BCRX
$2.35B
– –
-1,012,000
Closed -$16.5M
CGEM icon
99
Cullinan Oncology
CGEM
$1.1B
– –
-375,585
Closed -$3.93M
GDRX icon
100
GoodRx Holdings
GDRX
$1.07B
– –
-979,106
Closed -$18.9M
1 2 3
4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2022 Portfolio in Review

As of Q2 2022, Deerfield Management held 140 positions worth $4.85B, up 8.4% from $4.47B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Deerfield Management withdrew a net $1.26B in Q2 2022, closing 14 positions and reducing 12 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $22.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 54% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in HilleVax worth $28.6M.

  • Deerfield Management's largest Q2 2022 buy was HilleVax: 2,617,948 shares worth $28.6M.
  • Deerfield Management added most to Immunogen Inc in Q2 2022, an estimated $50.2M increase.
  • Deerfield Management's biggest Q2 2022 reduction was Kura Oncology, cutting an estimated $25.7M.
  • Deerfield Management fully exited Mirati Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $22.2M.
  • Deerfield Management's ten largest holdings make up 38% of its $4.85B portfolio in Q2 2022.
  • Deerfield Management opened 14 new positions and closed 14 in Q2 2022.
  • Deerfield Management's portfolio value rose 8.4% quarter-over-quarter to $4.85B.

Based on Deerfield Management's 13F filing for Q2 2022, filed 15 Aug 2022.